Mirikizumab for the Management of Ulcerative Colitis

被引：0
|
作者：
Venkateswaran, Niranjani [1 ]
机构：
[1] Hofstra Northwell, Zucker Sch Med, Gastroenterol & Hepatol, Hempstead, NY 11549 USA
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Mirikizumab for ulcerative colitis
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (10): : 785 - 785
  • [2] Mirikizumab for ulcerative Colitis
    Sievers, Laura Katharina
    Schreiber, Stefan
    Nitschmann, Sirka
    INNERE MEDIZIN, 2023, 64 (12): : 1230 - 1231
  • [3] Mirikizumab for ulcerative colitis
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (11): : 826 - 826
  • [4] Mirikizumab for ulcerative colitis
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (04): : 290 - 290
  • [5] Mirikizumab for ulcerative colitis
    Thorley, Jennifer
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (08): : 531 - 532
  • [6] Mirikizumab (Omvoh) for Ulcerative Colitis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1698): : 46 - 47
  • [7] Mirikizumab (Omvoh™ ) for ulcerative colitis
    Hammerhoj, Alexander
    Boye, Theresa Louise
    Langholz, Ebbe
    Nielsen, Ole Haagen
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (03) : 281 - 282
  • [8] Mirikizumab bei Colitis ulcerosaMirikizumab for ulcerative colitis
    Laura Katharina Sievers
    Stefan Schreiber
    Sirka Nitschmann
    Die Innere Medizin, 2023, 64 : 1230 - 1231
  • [9] An evaluation of mirikizumab for the treatment of ulcerative colitis
    White, Christopher
    Irving, Peter M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (11) : 1199 - 1206
  • [10] Mirikizumab for the treatment of moderate to severe ulcerative colitis
    Hanzel, Jurij
    Ma, Christopher
    Jairath, Vipul
    IMMUNOTHERAPY, 2023, 15 (15) : 1199 - 1208
12345